Arkolith/Insider Trading/TRML/Form 4

Castelein Caley

DirectorTourmaline Bio, Inc. (TRML) · full profile →Form 4 · filed Oct 27, 2023
Net Buying
Open-Market Buys
$281K
Open-Market Sells
$0
Net Open-Market Flow
$281K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 27, 2023Buy(P)16K$14.55$230K517K
Oct 25, 2023Buy(P)4K$12.07$51K501K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-053791) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML